Big money is flowing into the legal marijuana industry, and both Wall Street and investors have taken notice. By the end of the next decade, depending on your preferred source, Wall Street investment banks foresee anywhere from $50 billion to $75 billion in annual sales, placing cannabis on par with the global soda industry.
Among the individual pot stocks high on investors’ lists is the only major Atlantic-based grower, OrganiGram Holdings (NASDAQOTH:OGRMF). The company reported its second-quarter operating results before the opening bell this morning, swinging to a modest loss, but making significant progress on its production expansion, balance sheet improvement, and derivative development.
OrganiGram Holdings second-quarter results: The raw numbers
As you can see, it was a bifurcated quarter for OrganiGram, with gross revenue soaring more than 1,000%, and net revenue, which includes 6.6 million